Indolent triple negative breast cancer patients are more likely to develop late relapse compared to triple negative breast cancer patients with a high proliferation index

por Altundag, Kadri
Publicado 2023

Comment to “Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis”

por Altundag, Kadri
Publicado 2016

Comment on “Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer”

por Altundag, Kadri
Publicado 2017

Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer”

por Altundag, Kadri
Publicado 2017

Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'

por Altundag, Kadri
Publicado 2017

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

por Altundag, Kadri
Publicado 2017

Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?

por Altundag, Kadri
Publicado 2017

Immune evasion might affect survival in laryngeal cancer patients with blood group O

por Altundag, Kadri
Publicado 2017

Letter comments on: Drug–drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of patients with metastatic breast cancer

por Altundag, Kadri
Publicado 2022

Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey

por Akin, Serkan, Altundag, Kadri
Publicado 2018

The Clinicopathological Characteristics of Pure and Mixed Invasive Micropapillary Breast Carcinomas: A Single Center Experience

por Eren Kupik, Gülnihan, Altundağ, Kadri
Publicado 2022

Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis...

por Altundag, Kadri, Altundag, Ozden, Gunduz, Mehmet
Publicado 2004

Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview

por Karatas, Fatih, Sahin, Suleyman, Sever, Ali R., Altundag, Kadri
Publicado 2016

Cetuximab-induced esophageal ulcer: the first report in literature

por Babacan, Taner, Turkbeyler, Ibrahim Halil, Dag, Muhammet Sait, Dilli, Ismail, Balakan, Ozan, Altundag, Kadri
Publicado 2014

Effects of tamoxifen on urinary incontinence: Case report and review of literature

por Hasanov, Elshad, Hasanov, Merve, Kuria, Issa M., Hasanov, Rovshan, Rzazade, Reshad, Jonasch, Eric, Altundag, Kadri
Publicado 2017

Value of Dynamic (18)F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study

por Kupik, Osman, Tuncel, Murat, Özgen Kıratlı, Pınar, Akpınar, Meltem Gülsün, Altundağ, Kadri, Başaran Demirkazık, Figen, Erbaş, Belkıs
Publicado 2023

Assessment of psychosocial factors and distress in women having adjuvant endocrine therapy for breast cancer: the relationship among emotional distress and patient and treatment-re...

por Ates, Ozturk, Soylu, Cem, Babacan, Taner, Sarici, Furkan, Kertmen, Neyran, Allen, Deborah, Sever, Ali Riza, Altundag, Kadri
Publicado 2016

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast...

por Esteva, Francisco J, Wang, Jing, Lin, Feng, Mejia, Jaime A, Yan, Kai, Altundag, Kadri, Valero, Vicente, Buzdar, Aman U, Hortobagyi, Gabriel N, Symmans, W Fraser, Pusztai, Lajos
Publicado 2007

Stem cell-related markers in primary breast cancers and associated metastatic lesions

por Guler, Gulnur, Balci, Serdar, Costinean, Stefan, Ussakli, Cigdem Himmetoglu, Irkkan, Cigdem, Suren, Dinc, Sari, Ebru, Altundag, Kadri, Ozisik, Yavuz, Jones, Susie, Bacher, Jason, Shapiro, Charles L., Huebner, Kay
Publicado 2012

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

por Demir, Atakan, Mandel, Nil Molinas, Paydas, Semra, Demir, Gökhan, Er, Özlem, Turhal, Nazım Serdal, Bavbek, Sevil, Eralp, Yeşim, Saip, Pınar Mualla, Güler, Emine Nilüfer, Aydıner, Adnan, Oyan Uluç, Başak, Kılıçkap, Sadettin, Üskent, Necdet, Karadurmuş, Nuri, Kaplan, Mehmet Ali, Yanmaz, Mustafa Teoman, Demir, Hacer, Alan, Özkan, Korkmaz, Taner, Olgun, Polat, Sönmez Uysal, Özlem, Altundağ, Kadri, Gündüz, Şeyda, Günaldı, Meral, Sarı, Murat, Beypınar, İsmail, Başaran, Gül
Publicado 2020